+91-8668442535

Paranasal Sinus Cancer Market By Diagnosis (Medical history and physical examination, Imaging tests, Biopsy, Others) By Treatment (Surgery, Radiotherapy, Chemotherapy) By End User (Hospital & Clinics, Cancer Treatment & Research Center, Research Laboratories, Others)- Growth, Future Prospects, and Competitive Analysis, 2016 - 2028

About this report

The global Paranasal Sinus Cancer Market report explores the critical analysis of the paranasal sinus cancer industry using key parameters. The report consists of investment strategies, the need for investments in the paranasal sinus cancer industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the paranasal sinus cancer industry, as well as how economic and non-economic barriers are helping the paranasal sinus cancer market. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter's five forces analysis, PESTEL analysis, value chain analysis, etc.

paranasal-sinus-cancer-market

To learn how our report can help you streamline your business, Request Sample Here

Key Highlights of the report

How are the major segments performing in the Paranasal Sinus Cancer Market?

  • In 2021, imaging tests will be the leading segment. It is highly useful for examining malignancies of the paranasal sinuses and nasal cavities. They can distinguish between a fluid change and a malignancy.
  • In 2021, the surgery segment in the drug type will lead the market. The surgery removes the tumor. Cancer will also be removed if it has spread to the lymph nodes.
  • In 2021, the Hospital & Clinics segment in the end-user industry will lead the market. The category is expected to increase quickly during the projection due to rising disposable income and health concerns. 

Which region dominated the Paranasal Sinus Cancer Market?

In 2021, North America was one of the major contributors to the global paranasal sinus cancer market. The region's market is developing as a result of the region's well-established healthcare industry, rising healthcare expenditures, and rising rates of this rare type of cancer. Regional market expansion is also facilitated by cutting-edge technology and the presence of large competitors. A sophisticated healthcare sector and expanding government healthcare efforts contribute to the market's growth.

What is the competitive environment of the Paranasal Sinus Cancer Market?

Many market participants currently control the worldwide paranasal sinus cancer market. Major companies are launching new products and forming strategic alliances to increase their market position. Rising company cooperation with research institutes is projected to generate growth opportunities for manufacturers in the near future. For instance, in January 2018, G.E. Healthcare established a long-term strategic collaboration with Roche Diagnostics to co-develop and sell digital clinical decision support technologies.

Executive Summary

What are the different signs of paranasal sinus cancer?

One of the rare cancers is paranasal sinus carcinoma. The open regions behind the nose, known as sinuses, are home to cancerous growths called paranasal sinus tumors. Major signs and symptoms include nasal blockage and congestion; purulent rhinorrhea; facial pain or pressure; headaches; and fever. Another indicator and symptom are chronic sinus infections that do not resolve with antibiotic therapy. Loss of vision or bulging of one eye; teeth ache or numbness; teeth loosening; and a pain or lump within the nose that does not go away. The market is anticipated to develop during the projected period due to factors like an aging population, an increase in uncommon cancers, and technological advancements in cancer treatment. About 3% to 5% of all head and neck cancers in the U.S. are paranasal sinus and nasal cavity tumors, which are uncommon. People 55 years or older account for almost 4 out of 5 cases.

Which are the key investments by the players in the Paranasal Sinus Cancer Industry Market?

The main therapeutics firms invest extensively in research and development to create effective paranasal sinus cancer treatments with low or no adverse effects. The increasing penetration of the region's major pharmaceutical companies and increased investments in developing advanced healthcare infrastructure are boosting the market's growth. For instance, Eli Lilly purchased ARMO Biosciences for USD 1.6 billion to extend its cancer portfolio, which provided support for that portfolio.

Some of the major players in the paranasal sinus cancer market are AbbVie, Inc., Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Novartis AG, Ipsen Biopharmaceuticals Inc., Thermo Fisher Scientific, Abbott, G E Healthcare, Agilent Technologies Inc., AstraZeneca, Boehringer Ingelheim International GmbH and Bayer AG.

What are the Major Driving Factors for the Paranasal Sinus Cancer Market?

The market is anticipated to increase due to several factors, including rising chronic illness rates, rare cancer prevalence, technological improvements, and an aging population. An important factor that can support the growth of the paranasal sinus cancer market is the introduction of new products. Additionally, favorable healthcare costs fuel the market's expansion. The market is being stimulated by the increasing usage of telehealth platforms' education and consulting services and the increasing penetration of telehealth platforms globally.

What are the Major Risks for the Paranasal Sinus Cancer Market?

Advanced therapies are expensive, making it difficult for people with low and intermediate income levels to use them. A significant barrier to the sale of manufacturers' goods is the absence of healthcare insurance in developing and developing countries. But strict government regulations for product approval could impede market expansion during the evaluation period.

Which is the Key Treatment in the Paranasal Sinus Cancer Market?

In 2021, the surgery segment dominated the paranasal sinus cancer market. The most common treatment for paranasal sinus tumors is surgery. During surgery, get rid of as much of the tumor as possible. If the spread of cancer has impacted the lymph nodes, they will also be removed. The operation will be planned to preserve most of your face and its functions. Surgery can be challenging and involves a team of specialists, including maxillofacial surgeons, neurosurgeons, and otolaryngologists (ENT doctors or otorhinolaryngologists).

How is the Paranasal Sinus Cancer Market performing in regions?

In 2021, the global paranasal sinus cancer market was dominated by North America. The rising occurrence of this rare type of cancer, the region's well-developed healthcare industry, and rising healthcare expenditure fuel regional market expansion. Furthermore, well-developed technology and major market competitors promote regional market growth. The market is expanding due to the well-developed healthcare industry and expanding government initiatives in the healthcare sector. The increased use of cancer therapies and substantial funding from various organizations have created profitable growth prospects for key market competitors. The region's dominance is linked to the strategic presence of important firms in the United States and Canada.

Besides, the Asia-Pacific region is expected to grow significantly over the forecast period. The regional market is growing due to improving economic conditions and rising government support for the healthcare industry. Additionally, the already expanding markets of China and India will dominate the regional market because affordable treatments and medications are available to treat the ailment. Additionally, the size of the regional market is growing due to the large patient population suffering from paranasal sinus cancer. Additionally, it is anticipated that public and private groups' funding for research and development and changes to healthcare reimbursement laws will promote market expansion in the APAC region.

What is the regulatory landscape for the Paranasal Sinus Cancer Market?

The market is developing as a result of the funding provided by the government for research and rising healthcare costs. The market is anticipated to grow rapidly over the projected period due to increased regulatory approvals and an increase in cases of all types of cancer. In the U.S., healthcare spending is high per person. The United States spends about 18% of its GDP on healthcare overall. Increasing healthcare spending enables easier access to diagnostic tools and cutting-edge, ground-breaking paranasal sinus cancer treatments.

What is the Market Size of Paranasal Sinus Cancer regarding value?

The Paranasal Sinus Cancer Market is anticipated to grow at a substantial CAGR of 4.90% in the upcoming years. The global paranasal sinus cancer industry was estimated to be worth USD xx billion in 2021 and was expected to be worth USD xx billion by 2028.

What are the major players planning for the future of the Paranasal Sinus Cancer Market?

The development of different surgical procedures, radiation therapy, and chemotherapy is aided by manufacturers' adoption of cutting-edge technology like artificial intelligence (A.I.) and data analytics. In the future, market players should benefit from growth opportunities due to increased production and higher quality.

Segmentation of Global Paranasal Sinus Cancer Market-

Global Paranasal Sinus Cancer Market – By Diagnosis

  • Medical history and physical examination
  • Imaging tests
  • Biopsy
  • Others

Global Paranasal Sinus Cancer Market – By Treatment

  • Surgery
  • Radiotherapy
  • Chemotherapy

Global Paranasal Sinus Cancer Market – By End User

  • Hospital & Clinics
  • Cancer Treatment & Research Center
  • Research Laboratories
  • Others

Global Paranasal Sinus Cancer Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Frequently asked questions about the global Paranasal Sinus Cancer Industry

The global Paranasal Sinus Cancer market is expected to be impacted significantly by COVID-19.

North America accounted for the highest share in the global Paranasal Sinus Cancer market in terms of value.

The market is anticipated to increase due to several factors, including rising chronic illness rates, rare cancer prevalence, technological improvements, and an aging population.

The imaging tests segment had a significant share in 2021, with more than 30% of the market revenue share.

Surgery segment had a significant share in 2021, with more than 40% of the market revenue share.

Paranasal Sinus Cancer Market Scope

Report Attribute Details
Market Value in 2021 USD xx billion
Market Value in 2028 USD xx billion
CAGR 4.90%
Benchmarking Year 2021
Past data 2016 – 2021
Forecast period 2022 – 2028
Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Godaddy
Published Date:  Aug 2022
Category:  Pharmaceuticals
Report ID:   60621
Report Format:   PDF
Pages:   190
Rating:    4.8 (15)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support